1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(D)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)
------------------------------
DEKALB GENETICS CORPORATION
(Name of Subject Company)
DEKALB GENETICS CORPORATION
(Name of Person(s) Filing Statement)
CLASS B COMMON STOCK, WITHOUT PAR VALUE
(Title of Class of Securities)
244878 20 3
(CUSIP Number of Class of Securities)
John H. Witmer, Jr., Esq.
Senior Vice President and General Counsel
3100 Sycamore Road
DeKalb, Illinois 60115
(815) 758-3461
(Name, address and telephone number of person
authorized to receive notice and communications
on behalf of the person(s) filing statement)
------------------------------
COPIES TO:
James G. Archer Peter D. Lyons
Sidley & Austin Shearman & Sterling
875 Third Avenue 599 Lexington Avenue
New York, NY 10022 New York, NY 10022
(212) 906-2000 (212) 848-4000
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
2
ITEM 1. SECURITY AND SUBJECT COMPANY.
This Amendment No. 1 amends and supplements the Solicitation/Recommendation
Statement on Schedule 14D-9 filed with the Securities and Exchange Commission on
February 7, 1996 (as amended, the "Schedule 14D-9") by DEKALB Genetics
Corporation, a Delaware corporation (the "Company"), relating to the tender
offer by Monsanto Corporation, a Delaware corporation ("Monsanto"), to purchase
up to 1,800,000 shares of the Company's Class B Common Stock, without par value,
at a price per share of $71.00 net to the seller in cash, upon the terms and
subject to the conditions set forth in the Offer to Purchase of Monsanto dated
February 7, 1996 and in the related Letter of Transmittal.
ITEM 8. ADDITIONAL INFORMATION TO BE FURNISHED.
Item 8 of the Schedule 14D-9 is hereby amended and supplemented as follows:
On February 9, 1996, the Company issued a press release. A copy of such
press release is filed hereto as Exhibit 12, and is incorporated herein by
reference.
ITEM 9. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 12 Press Release of the Company dated February 9, 1996.
1
3
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
By: THOMAS R. RAUMAN
------------------------------------
Name: Thomas R. Rauman
Title: Chief Financial Officer
Dated: February 9, 1996
2
4
EXHIBIT INDEX
Exhibit 12 Press Release of the Company dated February 9, 1996
3